The cash-and-stock offer, which valued AstraZeneca at about $119 bn, would have created the world’s largest drug company
Read more
Pfizer says its bid for AstraZeneca is dead
Published in News
More from NewsMore posts in News »
- €500 million in private sector investments headed for Ukraine
- RBI asks banks to share information on exposure to Adani Group companies – Business Standard
- NSE puts some Adani firms under watch: What is additional surveillance mechanism (ASM)? – The Indian Express
- Hindenburg bet against India’s Adani puzzles rival U.S. short sellers – Reuters India
- Gautam Adani fails to calm investors as market wipeout hits $100 billion – CNN
